The Latest Breaking News from Abbott

Abbott issues warning about potential inaccuracies in FreeStyle Libre 3 blood sugar sensors, offering free replacements for affected devices.

Abbott is warning that sensors on some of its blood sugar monitoring systems may need to be replaced to prevent inaccurate readings

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

Abbott Laboratories gained U.S. clearance Monday for a pair of new CGMs. But Abbott stock fell a fraction at the close.

Despite Abbott’s recent underperformance over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

An apparent glitch at the operator of the New York Stock Exchange triggered volatility trading halts shortly after the open in about a dozen companies, including Chipotle Mexican Grill Inc. and Abbott Laboratories.

Abbott has underperformed the broader market over the past year, but Wall Street analysts are optimistic about the stock’s prospects.

Sprucing up your backyard for summer can be an expensive endeavor, but not with these deals